| Literature DB >> 28470080 |
Nelisiwe Mkize, Oliver T Zishiri1, Samson Mukaratirwa.
Abstract
Antimicrobial resistance of Staphylococcus aureus in human and veterinary medicine is a serious worldwide problem. The aim of this study was to investigate the prevalence of S. aureus in commercial broiler chickens as well as to establish antimicrobial susceptibility and the distribution of genetic determinants conferring resistance and virulence. One hundred and ninety-four samples were aseptically collected from broiler chicken slaughterhouses and retail outlets around the Durban metropolitan area in South Africa. Microbiological and molecular methods were used to detect the presence of S. aureus as well as its resistance- and virulence-associated genes. Polymerase chain reaction (PCR) was used to confirm the presence of S. aureus by amplifying the nuc gene. Approximately 54% of 194 samples were positive for S. aureus. The disc diffusion technique was used to investigate antimicrobial susceptibility profiles of the S. aureus isolates to a battery of 10 antimicrobial agents, namely ampicillin, chloramphenicol, gentamicin, erythromycin, cefoxitin, kanamycin, streptomycin, tetracycline, vancomycin and trimethoprim. The results demonstrated that S. aureus isolates of abattoir origin had a high level (79.4%) of resistance to tetracycline, followed by ampicillin, vancomycin, cefoxitin, trimethoprim, erythromycin and streptomycin with resistance rates of 65.1%, 61.9%, 60.3%, 58.7%, 57.1% and 46.0%, respectively. Staphylococcus aureus isolates of retail origin exhibited higher antimicrobial resistance prevalence rates than those of abattoir origin. Tetracycline had the highest resistance rate (100%), followed by cefoxitin (91.7%), erythromycin (83.3%), streptomycin (83.3%) and kanamycin (66.7%). All isolates were resistant to two or more antimicrobial agents. Out of the four virulence genes that were screened, only two were detected (coagulase and protein A); however, their prevalence rates were very low. All antimicrobial resistance genes screened were detected (mecA, BlaZ and tetK), although their prevalence did not correspond with antimicrobial susceptibility testing.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28470080 PMCID: PMC6138211 DOI: 10.4102/jsava.v88i0.1416
Source DB: PubMed Journal: J S Afr Vet Assoc ISSN: 1019-9128 Impact factor: 1.474
Sequences of oligonucleotide primers used to target genetic determinants responsible for species confirmation, virulence and resistance in Staphylococcus aureus.
| Target gene | Primer sequence (5’ 3’) | Product size (bp) | References |
|---|---|---|---|
| F: GCGATTGATGGTGATACGGTT | 270 | Brakstad et al. ( | |
| R:AGCCAAGCCTTGACGAACTA AAGC | |||
| F: CGA GAC CAA GAT TCA ACA AG | 730 | Aslantas et al. ( | |
| R: AAA GAA AAC CAC TCA CAT CA | |||
| F: CAA GCA CCA AAA GAG GAA | 320 | Frenay et al. ( | |
| R: CAC CAG GTT TAA CGA CAT | |||
| F: GCA GGG AAC AGC TTT AGGC | 521 | Monday and Bohach ( | |
| R: GTT CTG TAG AAG TAT GAAACA CG | |||
| F: TAC CAA TTA ACT TGT GGA TAG AC | 171 | Monday and Bohach ( | |
| R: CTC TTT GCA CCT TAC CGCA | |||
| F: AAAATCGATGGTAAAGGTTGGC | 532 | Strommenger et al. ( | |
| R: AGTTCTGCAGTACCGGATTTGC | |||
| F: ACTTCAACACCTGCTGCTTTC | 240 | Martineau et al. ( | |
| R: TAGGTTCAGATTGGCCCTTAG | |||
| F: TTAGGTGAAGGGTTAGGTCC | 718 | Aarestrup et al. ( | |
| R: GCAAACTCATTCCAGAAGCA |
FIGURE 1Agarose (1.5%) gel electrophoresis image of the nuc gene (270 bp). Lane M is a 50-bp DNA ladder, lanes 1 to 10 are test samples, lane 11 is a positive control and lane 12 is a negative control.
Prevalence rates for antimicrobial susceptibility tests on Staphylococcus aureus isolated from broiler chicken samples of different origins.
| Antibiotics | Abattoir samples ( | Retail samples ( | Faecal samples ( | ||||||
|---|---|---|---|---|---|---|---|---|---|
| R | I | S | R | I | S | R | I | S | |
| AMP | 41 (65.1) | 1 (1.6) | 21 (33.3) | 0 (0.0) | 0 (0.0) | 12 (100.0) | 8 (27.6) | 4 (14.0) | 17 (58.6) |
| C | 22 (34.9) | 4 (6.4) | 37 (58.7) | 5 (41.7) | 0 (0.0) | 7 (58.3) | 20 (69.0) | 1 (3.4) | 8 (27.6) |
| CN | 10 (15.9) | 2 (3.2) | 51 (81.0) | 3 (25.0) | 1 (8.3) | 8 (66.7) | 16 (55.2) | 4 (14.0) | 9 (31.0) |
| E | 36 (57.1) | 15 (23.8) | 12 (19.0) | 10 (83.3) | 2 (16.7) | 0 (0.0) | 18 (62.1) | 2 (6.9) | 9 (31.0) |
| FOX | 38 (60.3) | 2 (3.2) | 23 (36.5) | 11 (91.7) | 0 (0.0) | 1 (8.3) | 22 (76.0) | 1 (3.4) | 6 (20.7) |
| K | 21 (33.3) | 0 (0.0) | 42 (66.7) | 8 (66.7) | 0 (0.0) | 4 (33.3) | 23 (79.3) | 2 (6.9) | 4 (13.8) |
| S | 29 (46.0) | 2 (3.2) | 32 (50.8) | 10 (83.3) | 0 (0.0) | 2 (16.7) | 18 (62.1) | 4 (14.0) | 7 (24.1) |
| TE | 50 (79.4) | 4 (6.4) | 9 (14.3) | 12 (100) | 0 (0.0) | 0 (0.0) | 20 (69.0) | 1 (3.4) | 8 (27.6) |
| VA | 39 (61.9) | 4 (6.4) | 20 (31.7) | 0 (0.0) | 0 (0.0) | 12 (100.0) | 4 (14.0) | 3 (10.3) | 22 (75.9) |
| W | 37 (58.7) | 3 (4.8) | 23 (36.5) | 9 (75.0) | 0 (0.0) | 3 (25.0) | 17 (58.6) | 0 (0.0) | 12 (41.4) |
AMP, ampicillin; C, chloramphenicol; CN, gentamicin; E, erythromycin; FOX, cefoxitin; K, kanamycin; S, streptomycin; TE, tetracycline; VA, vancomycin; W, trimethoprim; R, resistant; I, intermediate susceptibility; S, susceptible.
Multiple-drug resistance patterns of Staphylococcus aureus isolates.
| Antimicrobial resistance patterns | Number of isolates (%) | ||
|---|---|---|---|
| Abattoir samples ( | Retail samples ( | Faecal samples ( | |
| FOX, AMP | 34 (54.0) | 0 (0.0) | 7 (24.1) |
| FOX, S, TE | 23 (36.5) | 9 (75.0) | 15 (51.7) |
| FOX, AMP, K | 12 (19.0) | 0 (0.0) | 7 (24.1) |
| FOX, C, CN | 8 (12.7) | 3 (25.0) | 10 (34.5) |
| FOX, K, TE | 16 (25.4) | 7 (58.3) | 17 (58.6) |
| FOX, W, S | 20 (31.7) | 7 (58.3) | 12 (41.4) |
| FOX, TE, VA | 30 (47.6) | 0 (0.0) | 4 (13.8) |
| FOX, CN, TE, K | 8 (12.7) | 3 (25.0) | 11 (37.9) |
| FOX, S, W, E | 16 (25.4) | 6 (50.0) | 11 (37.9) |
| FOX, E, S, VA | 14 (22.2) | 0 (0.0) | 4 (13.8) |
| FOX, K, CN, TE | 8 (12.7) | 3 (25.0) | 11 (37.9) |
| FOX, TE, E, C | 16 (25.4) | 5 (41.7) | 12 (41.4) |
| FOX, W, TE, K, S | 11 (17.5) | 5 (41.7) | 11 (37.9) |
| FOX, K, W, TE, E | 12 (19.0) | 6 (50.0) | 11 (37.9) |
| FOX, AMP, S, K, C | 11 (17.5) | 0 (0.0) | 7 (24.1) |
| FOX, C, VA, CN, TE | 6 (9.5) | 0 (0.0) | 3 (10.3) |
| FOX, TE, K, E, C | 12 (19.0) | 4 (33.3) | 12 (41.4) |
| FOX, W, CN,TE, VA, E | 5 (7.9) | 0 (0.0) | 4 (13.8) |
| FOX, VA, E, C,TE, W | 12 (19.0) | 0 (0.0) | 4 (13.8) |
| FOX, E, S, VA, TE, K | 9 (14.3) | 0 (0.0) | 4 (13.8) |
AMP, ampicillin; C, chloramphenicol; CN, gentamicin; E, erythromycin; FOX, cefoxitin; K, kanamycin; S, streptomycin; TE, tetracycline; VA, vancomycin; W, trimethoprim.
FIGURE 2Prevalence rates of genetic determinants encoding for virulence and resistance in Staphylococcus aureus isolates.